{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:21:09Z","timestamp":1780500069321,"version":"3.54.1"},"reference-count":29,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1134\/s1607672925700139","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T10:27:50Z","timestamp":1747045670000},"page":"369-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IL-17A, IL-17F, and IL-23 in Patients with Rheumatoid Arthritis"],"prefix":"10.1134","volume":"522","author":[{"given":"N. A.","family":"Lapkina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Baranov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. P.","family":"Rechkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. E.","family":"Abaytova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Zolotavkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Artyukhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"7686_CR1","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"M.J. McGeachy","year":"2019","unstructured":"McGeachy, M.J., Cua, D.J., and Gaffen, S.L., The IL-17 family of cytokines in health and disease, Immunity, 2019, vol. 50, no. 4, pp. 892\u2013906.","journal-title":"Immunity"},{"key":"7686_CR2","first-page":"68","volume":"55","author":"E.L. Nasonov","year":"2017","unstructured":"Nasonov, E.L., New possibilities of pharmacotherapy for immunoinflammatory rheumatic diseases: a focus on inhibitors of interleukin-17, Nauchno-Prakt. Revmatol., 2017, vol. 55, no. 1, pp. 68\u201386.","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7686_CR3","first-page":"400","volume":"57","author":"E.L. Nasonov","year":"2019","unstructured":"Nasonov, E.L., Korotaeva, T.V., Dubinina, T.V., and Lila, A.M., IL-23\/IL-17 inhibitors in immunoinflammatory rheumatic diseases: New horizons, Nauchno-Prakt. Revmatol., 2019, vol. 57, no. 4, pp. 400\u2013406.","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7686_CR4","first-page":"165","volume":"61","author":"E.L. Nasonov","year":"2023","unstructured":"Nasonov, E.L., Avdeeva, A.S., Korotaeva, T.V., Dubinina, T.V., and Usacheva, J.V., The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?, Nauchno-Prakt. Revmatol., 2023, vol. 61, no. 2, pp. 165\u2013180.","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7686_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41584-019-0243-5","volume":"15","author":"A. Beringer","year":"2019","unstructured":"Beringer, A. and Miossec, P., Systemic effects of IL-17 in inflammatory arthritis, Nat. Rev. Rheumatol., 2019, vol. 15, no. 8, pp. 491\u2013501.","journal-title":"Nat. Rev. Rheumatol."},{"key":"7686_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E. Lubberts","year":"2015","unstructured":"Lubberts, E., The IL-23-IL-17 axis in inflammatory arthritis, Nat. Rev. Rheumatol., 2015, vol. 11, no. 7, pp.\u00a0415\u2013429.","journal-title":"Nat. Rev. Rheumatol."},{"key":"7686_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.18786\/2072-0505-2019-47-058","volume":"47","author":"A.A. Novikov","year":"2019","unstructured":"Novikov, A.A., Aleksandrova, E.N., and Lukina, G.V., Serum cytokine profile in early and established rheumatoid arthritis, Almanac Clinical Medicine, 2019, vol.\u00a047, no. 5, pp. 393\u2013399.","journal-title":"Almanac Clinical Medicine"},{"key":"7686_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3760\/cma.j.issn.0366-6999.20113093","volume":"126","author":"Y.Y. Guo","year":"2013","unstructured":"Guo, Y.Y., Wang, N.Z., Zhao, S., Hou, L.X., Xu, Y.B., and Zhang, N., Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis, Chin. Med. J. (Engl.), 2013, vol. 126, no.\u00a05, pp. 850\u2013854.","journal-title":"Chin. Med. J. (Engl.)"},{"key":"7686_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejr.2015.01.001","volume":"38","author":"H.M. Al-Saadany","year":"2016","unstructured":"Al-Saadany, H.M., Hussein, M.S., Gaber, R.A., and Zaytoun, H.A., Th-17 cells and serum IL-17 in rheumatoid arthritis patients: correlation with disease activity and severity, Egypt. Rheumatol., 2016, vol. 38, no. 1, pp. 1\u20137.","journal-title":"Egypt. Rheumatol."},{"key":"7686_CR10","first-page":"85","volume":"20","author":"E.M. Abu Al Fadl","year":"2013","unstructured":"Abu Al Fadl, E.M., Fattouh, M., and Allam, A.A., High IL-23 level is a marker of disease activity in rheumatoid arthritis, Egypt. J. Immunol., 2013, vol. 20, no.\u00a02, pp. 85\u201392.","journal-title":"Egypt. J. Immunol."},{"key":"7686_CR11","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D. Aletaha","year":"2010","unstructured":"Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., and Felson, D.T., Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative, Arthritis Rheum., 2010, vol. 62, no. 9, pp. 2569\u20132581.","journal-title":"Arthritis Rheum."},{"key":"7686_CR12","doi-asserted-by":"crossref","unstructured":"Taams, L.S., Interleukin-17 in rheumatoid arthritis: trials and tribulations, J. Exp. Med., 2020, vol. 217, no. 3, p. e20192048.","DOI":"10.1084\/jem.20192048"},{"key":"7686_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/s41423-021-00644-5","volume":"18","author":"P. Miossec","year":"2021","unstructured":"Miossec, P., Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting, Cell Mol. Immunol., 2021, vol. 18, no. 4, pp. 860\u2013865.","journal-title":"Cell Mol. Immunol."},{"key":"7686_CR14","doi-asserted-by":"crossref","unstructured":"Liu, C., Chu, D., Kalantar-Zadeh, K., George, J., Young, H.A., and Liu, G., Cytokines: from clinical significance to quantification, Adv. Sci. (Weinh.), 2021, vol. 8, no. 15, p. e2004433.","DOI":"10.1002\/advs.202004433"},{"key":"7686_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10067-011-1737-y","volume":"30","author":"S.A. Metawi","year":"2011","unstructured":"Metawi, S.A., Abbas, D., Kamal, M.M., and Ibrahim,\u00a0M.Kh., Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA, Clin. Rheumatol., 2011, vol. 30, no. 9, pp.\u00a01201\u20131207. https:\/\/doi.org\/10.1007\/s10067-011-1737-y","journal-title":"Clin. Rheumatol."},{"key":"7686_CR16","doi-asserted-by":"crossref","unstructured":"Silo\u015fi, I., Boldeanu, M.V., Cojocaru, M., Biciu\u015fc\u0103, V., P\u0103dureanu, V., and Bogdan, M., The relationship of cytokines IL-13 and IL-17 with autoantibodies profile in early rheumatoid arthritis, J. Immunol. Res., 2016, vol. 2016, p. 3109135.","DOI":"10.1155\/2016\/3109135"},{"key":"7686_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/15321819.2019.1649695","volume":"40","author":"C.M. Costa","year":"2019","unstructured":"Costa, C.M., Santos, M., and Pernambuco, A.P., Elevated levels of inflammatory markers in women with rheumatoid arthritis, J. Immunoassay Immunochem., 2019, vol. 40, no. 5, pp. 540\u2013554.","journal-title":"J. Immunoassay Immunochem."},{"key":"7686_CR18","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.4155\/bio-2016-0207","volume":"8","author":"C. Schofield","year":"2016","unstructured":"Schofield, C., Fischer, S.K., Townsend, M.J., Mosesova, S., Peng, K., Setiadi, A.F., et al., Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis, Bioanalysis, 2016, vol. 8, no. 22, pp.\u00a02317\u20132327.","journal-title":"Bioanalysis"},{"key":"7686_CR19","doi-asserted-by":"crossref","unstructured":"Misra, S., Mondal, S., Chatterjee, S., Dutta, S., Sinha, D., and Bhattacharjee, D., Interleukin-17 as a predictor of subclinical synovitis in the remission state of rheumatoid arthritis, Cytokine, 2022, vol. 153, p.\u00a0155837.","DOI":"10.1016\/j.cyto.2022.155837"},{"key":"7686_CR20","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/annrheumdis-2014-207110","volume":"74","author":"N. Ndongo-Thiam","year":"2015","unstructured":"Ndongo-Thiam, N. and Miossec, P., A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis, Ann. Rheum. Dis., 2015, vol. 74, no. 8, pp. 1629\u20131631.","journal-title":"Ann. Rheum. Dis."},{"key":"7686_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/cei.12167","volume":"174","author":"N.J. Gullick","year":"2013","unstructured":"Gullick, N.J., Abozaid, H.S., Jayaraj, D.M., Evans, H.G., Scott, D.L., Choy, E.H., et al., Enhanced and persistent levels of interleukin (IL)-17+ CD4+ T cells and serum IL-17 in patients with early inflammatory arthritis, Clin. Exp. Immunol., 2013, vol. 174, no. 2, pp. 292\u2013301.","journal-title":"Clin. Exp. Immunol."},{"key":"7686_CR22","first-page":"999","volume":"40","author":"K. Lee","year":"2022","unstructured":"Lee, K., Min, H.K., Koh, S.H., Lee, S.H., Kim, H.R., Ju, J.H., et al., Prognostic signature of interferon-\u03b3 and interleurkin-17A in early rheumatoid arthritis, Clin. Exp. Rheumatol., 2022, vol. 40, no. 5, pp. 999\u20131005.","journal-title":"Clin. Exp. Rheumatol."},{"key":"7686_CR23","doi-asserted-by":"publisher","first-page":"r784","DOI":"10.1186\/ar1733","volume":"7","author":"K. Raza","year":"2005","unstructured":"Raza, K., Falciani, F., and Curnow, S.J., Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin, Arthritis Res. Ther., 2005, vol. 7, pp.\u00a0r784\u2013r795.","journal-title":"Arthritis Res. Ther."},{"key":"7686_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H. Kokkonen","year":"2010","unstructured":"Kokkonen, H., S\u00f6derstr\u00f6m, I., Rockl\u00f6v, J., Hallmans, G., Lejon, K., et al., Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis, Arthritis Rheum., 2010, vol. 62, pp. 383\u2013391.","journal-title":"Arthritis Rheum."},{"key":"7686_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.20071978","volume":"205","author":"X.O. Yang","year":"2008","unstructured":"Yang, X.O., Chang, S.H., Park, H., Nurieva, R., Shah, B., and Acero, L., Regulation of inflammatory responses by IL-17F, J. Exp. Med., 2008, vol. 205, no.\u00a05, pp. 1063\u20131075.","journal-title":"J. Exp. Med."},{"key":"7686_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/eji.201948138","volume":"50","author":"L.A. Burns","year":"2020","unstructured":"Burns, L.A., Maroof, A., Marshall, D., Steel, K., Lalnunhlimi, S., Cole, S., et al., Presence, function, and regulation of IL-17F-expressing human CD4+ T cells, Eur. J. Immunol., 2020, vol. 50, no. 4, pp. 568\u2013580.","journal-title":"Eur. J. Immunol."},{"key":"7686_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.intimp.2015.12.011","volume":"31","author":"D.S. Zaky","year":"2016","unstructured":"Zaky, D.S. and El-Nahrery, E.M., Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity, Int. Immunopharmacol., 2016, vol. 31, pp. 105\u2013108.","journal-title":"Int. Immunopharmacol."},{"key":"7686_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/rheumatology\/kel159","volume":"46","author":"H.R. Kim","year":"2007","unstructured":"Kim, H.R., Cho, M.L., Kim, K.W., Juhn, J.Y., Hwang,\u00a0\u00a0\u00a0S.Y., \u00a0and \u00a0Yoon, \u00a0C.H., \u00a0Up-regulation\u00a0 of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways, Rheumatology (Oxford), 2007, vol. 46, no. 1, pp. 57\u201364.","journal-title":"Rheumatology"},{"key":"7686_CR29","first-page":"397","volume":"61","author":"E.L. Nasonov","year":"2023","unstructured":"Nasonov, E.L., Modern concept of autoimmunity in rheumatology, Nauchno-Prakt. Revmatol., 2023, vol.\u00a061, no. 4, pp. 397\u2013420.","journal-title":"Nauchno-Prakt. Revmatol."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672925700139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:19:36Z","timestamp":1773760776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672925700139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7686"],"URL":"https:\/\/doi.org\/10.1134\/s1607672925700139","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol and design of the study were approved by the local Ethics Committee of the Yaroslavl State Medical University of the Ministry of Health Care of the Russian Federation (protocol no. 1 of January 29, 2015). The final protocol and design of the study were approved by the local Ethics Committee of Yaroslavl State Medical University of the Ministry of Health Care of the Russian Federation (protocol no. 44 of April 13, 2021). Before the start of the study, all patients signed informed consent to undergo examination and treatment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}}]}}